— Know what they know.
Not Investment Advice
Also trades as: MRK.DE (XETRA) · $vol 47M · MKGAF (OTC) · $vol 0M

MKKGY OTC

Merck KGaA
1W: +0.0% 1M: -4.7% 3M: -6.0% YTD: +8.3% 1Y: +8.9% 3Y: -3.6% 5Y: -29.7%
$30.87
+0.76 (+2.52%)
 
Weekly Expected Move ±3.4%
$29 $30 $31 $32 $33
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $67.1B mcap · 129M float · 0.059% daily turnover · Short 45% of daily vol

Cash Flow Trends

Operating Cash Flow
$3.8B -17.6% ▼
5Y CAGR: +1.7%
Capital Expenditures
$1.5B +30.3% ▲
5Y CAGR: -0.5%
Free Cash Flow
$2.3B -6.1% ▼
5Y CAGR: +3.3%
Dividends Paid
$998M -251.4% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
$521M -2.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$3.1B$3.3B$2.8B$2.8B$2.5B
Depreciation & Amort.$1.8B$2.0B$1.8B$2.1B$1.8B
Stock-Based Comp.$3M-$7M$2M$0$0
Change in Working Capital-$274M-$1.1B-$707M-$310M-$782M
Other Non-Cash Items$63M-$28M-$117M-$24M$248M
Operating Cash Flow$4.6B$4.3B$3.8B$4.6B$3.8B
— Investing Activities —
Capital Expenditures-$1.4B-$1.8B-$1.8B-$1.7B-$3.4B
Acquisitions (Net)-$4M-$850M-$12M-$767M-$2.8B
Investment Purchases-$269M-$364M-$537M$0$0
Investment Sales$70M$219M$510M$0$399M
Other Investing$46M$58M-$46M-$581M$1.7B
Investing Cash Flow-$1.6B-$2.7B-$1.9B-$3.0B-$4.1B
— Financing Activities —
Net Debt Issuance-$1.7B-$589M-$148M$53M$1.6B
Stock Repurchased$0$0$0$0$0
Dividends Paid-$748M-$955M-$1.2B-$284M-$998M
Other Financing-$9M-$11M-$432M-$754M-$10M
Financing Cash Flow-$2.5B-$1.6B-$1.7B-$985M$603M
Net Change in Cash$544M-$45M$128M$535M$521M
Cash End of Period$1.9B$1.9B$2.0B$2.5B$2.7B
Free Cash Flow$3.2B$2.5B$1.8B$2.4B$2.3B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms